Remote Patient Monitoring For Management of Diabetes Melitus in Pregnancy
Remote Patient Monitoring For Management of Diabetes Melitus in Pregnancy
Remote Patient Monitoring For Management of Diabetes Melitus in Pregnancy
org
OBSTETRICS
Remote patient monitoring for management of diabetes
mellitus in pregnancy is associated with improved
maternal and neonatal outcomes
Agata Kantorowska, MD; Koral Cohen, BA; Maxwell Oberlander, BA; Anna R. Jaysing, BA; Meredith B. Akerman, MS;
Anne-Marie Wise, NP; Devin M. Mann, MD; Paul A. Testa, MD; Martin R. Chavez, MD; Anthony M. Vintzileos, MD;
Hye J. Heo, MD
BACKGROUND: Diabetes mellitus is a common medical complication intraventricular hemorrhage, necrotizing enterocolitis, sepsis, pneumonia,
of pregnancy, and its treatment is complex. Recent years have seen an seizures, hypoxic ischemic encephalopathy, shoulder dystocia, trauma,
increase in the application of mobile health tools and advanced technol- brain or body cooling, and neonatal intensive care unit admission). Sec-
ogies, such as remote patient monitoring, with the aim of improving care ondary outcomes were measures of glycemic control and the individual
for diabetes mellitus in pregnancy. Previous studies of these technologies components of the primary composite outcomes. We also performed a
for the treatment of diabetes in pregnancy have been small and have not secondary analysis in which the patients who used the two different
clearly shown clinical benefit with implementation. remote patient monitoring options (device integration vs manual entry)
OBJECTIVE: Remote patient monitoring allows clinicians to monitor pa- were compared. Chi-square, Fisher’s exact, 2-sample t, and Mann-
tients’ health data (such as glucose values) in near real-time, between office Whitney tests were used to compare the groups. A result was consid-
visits, to make timely adjustments to care. Our objective was to determine if ered statistically significant at P<.05.
using remote patient monitoring for the management of diabetes in pregnancy RESULTS: Maternal baseline characteristics were not significantly
leads to an improvement in maternal and neonatal outcomes. different between the remote patient monitoring and paper groups aside
STUDY DESIGN: This was a retrospective cohort study of pregnant from a slightly higher baseline rate of chronic hypertension in the remote
patients with diabetes mellitus managed by the maternal-fetal medicine patient monitoring group (6.1% vs 1.2%; P=.011). The primary outcomes
practice at one academic institution between October 2019 and April of composite maternal and composite neonatal morbidity were not
2021. This practice transitioned from paper-based blood glucose logs to significantly different between the groups. However, remote patient
remote patient monitoring in February 2020. Remote patient monitoring monitoring patients submitted more glucose values (177 vs 146; P=.008),
options included (1) device integration with Bluetooth glucometers that were more likely to achieve glycemic control in target range (79.2% vs
automatically uploaded measured glucose values to the patient’s Epic 52.0%; P<.0001), and achieved the target range sooner (median, 3.3 vs
MyChart application or (2) manual entry in which patients manually logged 4.1 weeks; P¼.025) than patients managed with paper logs. This was
their glucose readings into their MyChart application. Values in the achieved without increasing in-person visits. Remote patient monitoring
MyChart application directly transferred to the patient’s electronic health patients had lower rates of preeclampsia (5.8% vs 15.0%; P¼.0006) and
record for review and management by clinicians. In total, 533 patients their infants had lower rates of neonatal hypoglycemia in the first 24 hours
were studied. We compared 173 patients managed with paper logs to 360 of life (29.8% vs 51.7%; P<.0001).
patients managed with remote patient monitoring (176 device integration CONCLUSION: Remote patient monitoring for the management of
and 184 manual entry). Our primary outcomes were composite maternal diabetes mellitus in pregnancy is superior to a traditional paper-based
morbidity (which included third- and fourth-degree lacerations, cho- approach in achieving glycemic control and is associated with improved
rioamnionitis, postpartum hemorrhage requiring transfusion, postpartum maternal and neonatal outcomes.
hysterectomy, wound infection or separation, venous thromboembolism,
and maternal admission to the intensive care unit) and composite neonatal Key words: device integration, euglycemia, glycemic control, glycemic
morbidity (which included umbilical cord pH <7.00, 5 minute Apgar score surveillance, hyperglycemia, large for gestational age, mobile health,
<7, respiratory morbidity, hyperbilirubinemia, meconium aspiration, neonatal hypoglycemia, normoglycemia, telehealth, telemedicine
review the glucose logs at a designated practice. Exclusion criteria included pa- RPM platform. The 360 patients in the
frequency (1 to 2 times a week). A key tients who declined to send any logs for RPM group were the ones enrolled in the
difference was that when a patient review to the practice, those who were program between February 2020 and
inputted values that were outside a range lost to follow-up, or those who delivered April 2021 (the study endpoint). We
of set parameters (blood glucose of >140 at an outside institution; 34 patients were also performed a secondary analysis
and <60), the clinical team was alerted excluded based on these criteria comparing patients who used the two
via InBasket and the patient’s (Figure 1). A total of 533 subjects were different RPM options, namely 184 pa-
RPMebased glucose data could be included in our primary analysis, with tients who used manual entry vs 176 who
reviewed more expeditiously by the 173 patients managed with traditional used device integration.
team. During the study time frame, there paper glucose logs and 360 patients Data on maternal demographics
were no other changes implemented in managed using the EHR-integrated RPM (Table 1), measures of glycemic control,
diabetic management, and the same platform. The 173 patients managed and obstetrical outcomes were extracted
team provided diabetes care. with paper logs were the patients from the patients’ charts. Data on
Between October 2019 and April 2021, managed by the practice between neonatal outcomes were collected from
567 patients with GDM and type II dia- October 2019 and February 2020 before record review of the infants’ charts.
betes mellitus were managed by the implementation of the EHR-integrated Glycemic measures collected included
number of blood glucose values recor-
ded, mean number of blood glucose
FIGURE 1 values per week, and the number and
Patient groups types of encounters for diabetes mellitus
management (see full list of variables in
Table 2). Glycemic control was defined as
having at least two consecutive encoun-
ters where the patient’s blood glucose
report showed that the majority (70%)
of values were in target range, and no
adjustments were made to the thera-
peutic plan. The number of changes to
glycemic management was defined as
number of changes to medication
regimen.
Obstetrical data collected included
gestational age at delivery, mode of de-
livery, rates of gestational hypertension
and preeclampsia, and the presence of
shoulder dystocia (full list of variables is
shown in Table 3). Neonatal data collected
included birthweight, length, ponderal
index (calculated as kg/m3),45 first
neonatal glucose level, neonatal hypogly-
cemia (blood glucose <40), and presence
of multiple episodes of neonatal hypo-
glycemia in the first 24 hours of life
(variables are shown in Table 4). Birth-
weight percentile was obtained using the
calculator provided by the Fetal Medicine
Foundation for birthweight assess-
ment.46,47 Large for gestational age (LGA)
was defined as birthweight exceeding the
90th percentile.
The primary outcomes for compari-
son between the RPM and paper glucose
Flowchart of patients included in the study. log groups were composite maternal
RPM, remote patient monitoring. morbidity and composite neonatal
Kantorowska. Remote patient monitoring for diabetes mellitus in pregnancy improves outcomes. Am J Obstet Gynecol 2023. morbidity. Composite maternal morbidity
was defined as any of the following
TABLE 1
Maternal demographics for remote patient monitoring vs paper glucose log groups
Remote patient Paper glucose
Characteristics monitoring (n¼360) logs (n¼173) P value
Age (y) 33.44.8 34.34.65 .054
Pre-pregnancy BMI 30.26.8 29.96.8 .670
BMI on delivery admission 33.66.5 33.56.7 .909
Nulliparity 156 (43.3%) 79 (45.7%) .648
Race and ethnicity:
White, non-Hispanic 174 (48.3%) 78 (45.1%)
African American 44 (12.2%) 17 (9.8%)
Hispanic 44 (12.2%) 29 (16.8%) .615
Asian, Indian, or Pacific Islander 79 (21.9%) 40 (23.1%)
Other 19 (5.3%) 9 (5.2%)
Primary language
English 336 (93.3%) 154 (89.0%)
Spanish 16 (4.4%) 16 (9.3%) .095
Other 8 (2.2%) 3 (1.7%)
Primary OB/GYN:
Faculty 192 (53.3%) 93 (53.7%) 1.000
Private 168 (46.7%) 80 (46.2%)
Insurance type:
Medicaid 93 (25.8%) 45 (26.0%)
Private 241 (66.9%) 107 (61.9%) .163
Other or military 26 (7.2%) 21 (12.1%)
Multiple gestation 7 (1.9%) 5 (2.9%) .538
Chronic HTN 22 (6.1%) 2 (1.2%) .011
Type of diabetes mellitus:
Gestational, A1 or A2 341 (94.7%) 166 (95.9%) .462
Pre-gestational type II 19 (5.3%) 7 (4.1%)
Previous GDM 61 (17.0%) 30 (17.3%) 1.000
Gestational age at initial diabetic encounter (wk) 27.25.9 27.85.5 .286
Hemoglobin A1c (%) before diabetes mellitus diagnosis 5.4 (5.1e5.8) 5.4 (5.2e5.7) .841
GCT value 164 (147e187) 167 (151e190) .453
GTT values:
Fasting value 86 (78e95) 88 (77e96) .816
Hour 1 201 (188e214) 202 (186e210) .787
Hour 2 172 (159e190) 176 (162e197) .169
Hour 3 134 (110e153) 139 (119e156) .054
Non-normally distributed continuous variables were presented as median (25the75th percentiles) and normally distributed variables were presented as meanstandard deviation; categorical
variables were presented as frequency (percentage).
BMI, body mass index; GCT, glucose challenge test; GDM, gestational diabetes mellitus; GTT, glucose tolerance test; HTN, hypertension; OB/GYN, obstetrician-gynecologist.
Kantorowska. Remote patient monitoring for diabetes mellitus in pregnancy improves outcomes. Am J Obstet Gynecol 2023.
TABLE 2
Glycemic control characteristics of study groups: standard diabetic management with paper glucose logs vs remote
patient monitoring
Remote patient monitoring Paper glucose logs
Characteristics (n¼360) (n¼173) P value
Percentage of mothers who achieved glycemic control a
285 (79.2%) 90 (52.0%) <.0001
Number of blood glucose values recorded 177 (116e260) 146 (95e235) .008
Mean number of glucose values per wk 22.6 (17.5e26.2) 22.3 (18.4e25.8) .685
Number of encounters for management of diabetes mellitus:
In-person 0 (0e1) 2 (2e3) <.0001
Telemedicine 3 (1e3) 0 (0e0) <.0001
Phone calls or messages 9 (6e14) 5 (3e9) <.0001
Total 12 (9e17) 8 (5e12) <.0001
a
Number of weeks until glycemic control achieved 3.3 (2.1e5.5) 4.1 (2.6e6.8) .025
a
Gestational age when glycemic control achieved 32.7 (30.3e34.7) 32.8 (30.4e35.9) .472
Percentage of mothers who were started on metformin 100 (27.8%) 48 (27.8%) .994
Percentage of mothers who were started on insulin 103 (28.7%) 49 (28.3%) .930
Final insulin dose (units) 36 (16e58) 44 (23e60) .195
Number of changes to glycemic management 4 (2e10) 4 (2e8) .455
Non-normally distributed continuous variables were presented as median (25the75th percentiles) and normally distributed variables were presented as meanstandard deviation; categorical
variables were presented as frequency (percentage).
a
Defined as 2 consecutive patient encounters with majority of blood glucose values in target range and no changes to diabetic management.
Kantorowska. Remote patient monitoring for diabetes mellitus in pregnancy improves outcomes. Am J Obstet Gynecol 2023.
maternal complications: third- or fourth- normally distributed continuous vari- proportion of patients with chronic hy-
degree perineal laceration, chorioamnio- ables; frequencies and percentages for pertension (6.1% vs 1.2%; P¼.011).
nitis or endometritis, postpartum categorical variables) were calculated Comparisons between the groups for
hemorrhage requiring blood transfusion, separately for each group (RPM vs paper glycemic control variables are shown in
postpartum hysterectomy, wound infec- logs and manual entry vs device inte- Table 2. Patients in the RPM group had
tion or separation, venous thromboem- gration). Univariate analyses were per- more blood glucose values available for
bolism, and maternal admission to the formed using chi-square or Fisher’s exact review than patients who submitted
ICU.48 Composite neonatal morbidity was tests, as deemed appropriate, for cate- paper logs (median, 177 vs 146;
defined as any of the following neonatal gorical variables and the 2-sample t test P¼.008). The RPM group had less in-
complications: umbilical cord pH <7.00, 5 or Mann-Whitney test for continuous person visits than the paper log group
minute Apgar score <7, respiratory measures. A result was considered sta- and, instead, relied more on telehealth
morbidity, hyperbilirubinemia requiring tistically significant at a P value <.05. All platforms (with an increase in tele-
phototherapy, meconium aspiration, analyses were performed using SAS medicine and virtual contacts). Patients
intraventricular hemorrhage, necrotizing (version 9.4) (SAS Institute Inc, Cary, managed with RPM were significantly
enterocolitis, sepsis, pneumonia, seizures, NC). more likely to achieve glycemic control
hypoxic ischemic encephalopathy, shoul- than patients with paper glucose logs
der dystocia, trauma, brain or body cool- Results (79.2% vs 52.0%; P<.0001). Patients in
ing, and NICU admission.48 Secondary The maternal demographic characteris- the RPM group also achieved the gly-
outcomes included measures of glycemic tics are shown in Table 1. Overall, the cemic target in a shorter time period
control, as previously described, and in- maternal baseline characteristics were than the patients managed with paper
dividual obstetrical and neonatal not significantly different between the glucose logs (median, 3.3 weeks vs 4.1
outcomes. RPM and paper glucose log groups, weeks; P¼.025).
The overall descriptive statistics including similar rates of GDM (94.7% Pregnancy, delivery, and maternal
(meanstandard deviation for normally vs 95.9%) and pregestational diabetes outcomes are shown in Table 3.
distributed continuous variables and mellitus (5.3% vs 4.1%). The RPM Mothers with diabetes mellitus in
median and interquartile range for non- group did have a significantly higher pregnancy managed using RPM had a
TABLE 3
Pregnancy, delivery, and maternal outcomes: standard diabetic management with paper glucose logs vs remote
patient monitoring
Remote patient Paper glucose
Outcomes monitoring (n¼360) logs (n¼173) P value
Antenatal corticosteroids 26 (7.2%) 9 (5.2%) .378
Gestational hypertension 21 (5.8%) 5 (2.9%) .201
Preeclampsia 21 (5.8%) 26 (15.0%) .0008
Gestational age at delivery (wk) 38.31.7 38.41.5 .543
Induction of labor 136 (37.8%) 58 (33.5%) .340
Mode of delivery:
NSVD 187 (51.9%) 82 (47.4%)
Operative delivery 6 (1.7%) 6 (3.5%) .451
Cesarean delivery 162 (45.0%) 82 (47.4%)
VBAC 5 (1.4%) 3 (1.7%)
Third- or fourth-degree laceration 7 (1.9%) 3 (1.7%) 1.000
Shoulder dystocia 2 (0.6%) 2 (1.2%) .599
Chorioamnionitis or endometritis 6 (1.7%) 7 (4.1%) .131
Postpartum hemorrhage requiring blood transfusion 5 (1.4%) 3 (1.7%) .719
Postpartum hysterectomy 0 0 1.000
Wound infection or separation 0 0 1.000
VTE 0 0 1.000
Maternal admission to ICU 1 (0.28%) 0 (0.0%) 1.000
a
Composite maternal morbidity :
0 342 (95.0%) 160 (92.5%)
1 17 (4.7%) 13 (7.5%) .378
2 1 (0.3%) 0 (0.0%)
Non-normally distributed continuous variables were presented as median (25the75th percentiles) and normally distributed variables were presented as meanstandard deviation; categorical
variables were presented as frequency (percentage).
ICU, Intensive Care Unit; NSVD, normal spontaneous vaginal delivery; VBAC, vaginal birth after cesarean; VTE, venous thromboembolism.
a
Composite maternal morbidity based on the following variables: third- or fourth-degree laceration, chorioamnionitis o endometritis, postpartum hemorrhage requiring blood transfusion, postpartum
hysterectomy, wound infection or separation, VTE, and maternal admission to ICU.
Kantorowska. Remote patient monitoring for diabetes mellitus in pregnancy improves outcomes. Am J Obstet Gynecol 2023.
significantly lower rate of preeclampsia with diabetes mellitus managed using proportion of LGA in the RPM group,
than patients managed with paper RPM developed hypoglycemia (glucose but this did not reach statistical signifi-
glucose logs (5.8% vs 15.0%; P¼.0006). <40 in the first 24 hours of life) at a cance. Other neonatal outcomes, such as
This is despite the higher baseline significantly lower rate than infants of Apgar scores, NICU admission, hyper-
proportion of patients with chronic mothers managed using paper glucose bilirubinemia requiring phototherapy,
hypertension in the RPM group. Other logs (29.8% vs 51.7%; P<.0001). Infants and composite neonatal morbidity were
pregnancy and delivery outcomes, such of mothers managed using RPM were not significantly different.
as mode of delivery, rate of shoulder also found to have a significantly lower Figure 2 depicts a graphic represen-
dystocia, and composite maternal median birthweight percentile than in- tation of the statistically significant re-
morbidity did not reach statistical fants of mothers managed using paper sults. Mothers with diabetes mellitus
significance. logs (45.5% vs 56%; P¼.048). The rate managed using RPM had a markedly
Neonatal outcomes for the two groups of LGA infants in the two groups increased rate of achieving glycemic
are shown in Table 4. Infants of mothers showed a trend toward decreased control. This was associated with a
TABLE 4
Neonatal outcomes: comparison of standard diabetic management with paper glucose logs vs remote patient
monitoring
Remote patient Paper glucose
Outcomes monitoring (n¼360) logs (n¼173) P value
Birthweight (g) 3184.9535.4 3264.1507.3 .104
Birthweight percentile 45.5 (23e73) 56 (26e78) .048
Ponderal index 3.07.1 2.50.3 .283
LGA 43 (11.9%) 23 (13.3%) .658
Apgar, 1 min 9 (9e9) 9 (9e9) .643
Apgar, 5 min 9 (9e9) 9 (9e9) .406
First neonatal glucose:
<30 16 (4.5%) 4 (2.3%)
30e45 65 (18.1%) 41 (23.8%) .173
>45 278 (77.4%) 121 (73.8%)
Neonatal hypoglycemia 107 (29.8%) 89 (51.7%) <.0001
Multiple episodes of hypoglycemia in first 24 h 50 (46.7%) 39 (43.8%) .818
Hyperbilirubinemia requiring phototherapy 47 (13.1%) 33 (19.1%) .069
Umbilical cord pH <7.00 1 (0.3%) 2 (1.5%) .205
5 min Apgar <7 3 (0.8%) 1 (0.6%) 1.000
Respiratory morbidity 24 (6.7%) 16 (9.3%) .294
Meconium aspiration 0 (0.0%) 0 (0.0%) 1.000
Intraventricular hemorrhage 3 (0.9%) 2 (1.2%) .662
Necrotizing enterocolitis 1 (0.3%) 0 (0.0%) 1.000
Sepsis 1 (0.3%) 1 (0.6%) .544
Pneumonia 0 (0.0%) 1 (0.6%) .323
Seizures 0 (0.0%) 0 (0.0%) 1.000
Hypoxic ischemic encephalopathy 0 (0.0%) 1 (0.6%) .325
Trauma 1 (0.3%) 2 (1.2%) .248
Brain or body cooling 0 (0.0%) 1 (0.6%) .325
NICU admission 66 (18.3%) 39 (22.5%) .524
a
Composite neonatal morbidity 0.420.82 0.581.03 .100
Neonatal hospitalization (d) 3.47.3 3.77.4 <.0001
Non-normally distributed continuous variables were presented as median (25the75th percentiles) and normally distributed variables were presented as meanstandard deviation; categorical
variables were presented as frequency (percentage).
LGA, large for gestational age; NICU, neonatal intensive care unit.
a
Composite neonatal morbidity based on the following variables: shoulder dystocia, hyperbilirubinemia requiring phototherapy, umbilical cord pH <7.00, 5 min APGAR <7, respiratory morbidity,
meconium aspiration, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, pneumonia, seizures, hypoxic ischemic encephalopathy, trauma, brain or body cooling, and NICU admission.
Kantorowska. Remote patient monitoring for diabetes mellitus in pregnancy improves outcomes. Am J Obstet Gynecol 2023.
decreased rate of maternal preeclam- coverage was noted be different between Comment
psia and a lower rate of neonatal the groups. There was no statistically Principal findings
hypoglycemia. significant difference in any clinical Overall, this study showed that imple-
A secondary analysis comparing the outcomes, demonstrating that clinical mentation of RPM for the management
different modes of RPM (manual entry benefits are still preserved with manual of diabetes mellitus in pregnancy is
vs device integration) is shown in entry of glucose readings into the pa- associated with improvement in clinical
Table 5. Only the type of insurance tient’s health portal. outcomes. The primary outcomes of
TABLE 5
Comparison of remote patient monitoring for diabetes: manual entry vs device integration
Manual entry of glucose Device integration
Characteristics values (n¼184) (n¼176) P value
Insurance type:
Medicaid 62 (33.7%) 31 (17.6%)
Private 113 (61.4%) 128 (72.7%) .0014
Other or military 9 (4.9%) 17 (9.7%)
a
Percentage of mothers who achieved glycemic control 147 (79.9%) 138 (78.4%) .729
Number of blood glucose values recorded 168 (111e244) 183 (126e271) .172
Number of encounters for management of diabetes mellitus:
In-person 0 (0e1) 0 (0e1) .292
Telemedicine 2 (1e3) 3 (1e3) .573
Phone calls or messages 9 (6e13) 9 (6e15) .347
Total 12 (9e16) 13 (9e19) .294
Number of weeks until glycemic controla achieved 3.2 (2.1e6.2) 3.3 (2.2e5.3) .583
Rate of preeclampsia (%) 9 (4.9%) 12 (6.8%) .059
Rate of neonatal hypoglycemia (%) 57 (31.2%) 50 (28.4%) .571
Birthweight percentile 46.630.7 48.928.5 .450
Non-normally distributed continuous variables were presented as median (25the75th percentiles) and normally distributed variables were presented as meanstandard deviation; categorical
variables were presented as frequency (percentage).
a
Defined as 2 consecutive patient encounters with the majority of blood glucose values in the target range and no changes to diabetes mellitus management.
Kantorowska. Remote patient monitoring for diabetes mellitus in pregnancy improves outcomes. Am J Obstet Gynecol 2023.
these benefits without needing to in- application for recording their values management of diabetes in pregnancy
crease their in-person encounters. These and clinicians do not need to log into a was equally effective at improving gly-
results suggest that use of RPM and other separate system to view these values or to cemic control and improving maternal
types of advanced technologies should make adjustments to therapeutic man- and neonatal outcomes. However, larger
become more widespread in the care of agement. RPM allows review of data and studies are needed to confirm this
pregnant women. RPM gives clinicians a updates to a patient’s therapeutic plan as particular finding.
superior platform to review patients’ frequently as needed, even between
health data—they no longer have to rely visits. Research implications
on a patient remembering to write down It is important to note that the two Future studies should focus on scaling
their blood sugar levels on a piece of types of RPM modalities, manual entry and generalizing these data. Imple-
paper or to bring that paper in during and device integration, did not show a mentation of RPM for the management
clinical visits. Smartphones are ubiqui- significant difference in any clinical of diabetes mellitus in pregnancy at
tous in our modern world,49,50 meaning outcomes when compared with each other institutions would reveal the
that patients managed with RPM do not other. Insurance coverage dictated feasibility of this approach in the context
have to reach far to record their blood whether patients could be provided with of individual hospital infrastructure and
glucose values. Or, in the case of device Bluetooth-enabled glucometers. Our would strengthen the current findings.
integration, they no longer have to results suggest that although there is Examining larger cohorts of patients
remember to record anything at all inequity among patients enrolling in may also reveal statistical significance for
because their Bluetooth glucometer RPM based on their insurance coverage, rarer outcomes, such as the various
automatically uploads the measured the overall care they received and their components of the maternal and
values. RPM that is integrated into a clinical outcomes were equitable. neonatal composite morbidities.
patient’s health portal application is Although reimbursement for RPM ser- It would also be interesting to obtain
additionally beneficial because every- vices requires use of device-integrated data on patient satisfaction with RPM,
thing is in a central location. The patient platforms, we found that manual entry particularly from patients who may have
does not need to rely on a separate of recordings using RPM for the had a pregnancy managed by standard
management with paper glucose logs in associated with better outcomes than a 10. Lemelin A, Paré G, Bernard S, Godbout A.
the past and who then transitioned to traditional paper-based approach. RPM Demonstrated cost-effectiveness of a tele-
homecare program for gestational diabetes
RPM when they developed diabetes is more effective in achieving maternal mellitus management. Diabetes Technol Ther
mellitus in a subsequent pregnancy. glycemic control and leads to improved 2020;22:195–202.
maternal and neonatal outcomes with 11. Hirst JE, Mackillop L, Loerup L, et al.
Strengths and limitations decreased maternal preeclampsia and Acceptability and user satisfaction of a
Strengths of this study include the large neonatal hypoglycemia. Efforts should smartphone-based, interactive blood glucose
management system in women with gestational
sample size when compared with previ- be made to transition practices that still diabetes mellitus. J Diabetes Sci Technol
ous studies on this topic and the reliably use traditional paper-based methods for 2015;9:111–5.
collected data by extraction from indi- management of diabetes mellitus in 12. Al-Ofi EA, Mosli HH, Ghamri KA, Ghazali SM.
vidual charts in the EHR system for each pregnancy to a new era of RPM and Management of postprandial hyperglycaemia
patient and neonate. Another strength mobile health tools. Incorporating and weight gain in women with gestational
diabetes mellitus using a novel telemonitoring
was the uniform management by the technology in the management of dia- system. J Int Med Res 2019;47:754–64.
same of group of clinicians for the dura- betes in pregnancy seems to improve 13. Guo H, Zhang Y, Li P, Zhou P, Chen LM,
tion of this study. This ensured that aside patient outcomes. We hope future ran- Li SY. Evaluating the effects of mobile health
from the introduction of RPM, no other domized controlled trials confirm our intervention on weight management, glycemic
changes were made to the management of findings. n control and pregnancy outcomes in patients
with gestational diabetes mellitus. J Endocrinol
these patients with diabetes mellitus. Invest 2019;42:709–14.
Performing a secondary analysis to References 14. Ming WK, Mackillop LH, Farmer AJ, et al.
evaluate individual outcomes between the 1. Tozour JN, Bandremer S, Patberg E, et al. Telemedicine technologies for diabetes in preg-
manual entry and device integration Application of telemedicine video visits in a nancy: a systematic review and meta-analysis.
groups was beneficial to show that the two maternal-fetal medicine practice at the J Med Internet Res 2016;18:e290.
epicenter of the COVID-19 pandemic. Am J 15. Alqudah A, McMullan P, Todd A, et al. Ser-
modalities of RPM were similar and that it vice evaluation of diabetes management during
Obstet Gynecol MFM 2021;3:100469.
was appropriate to combine the outcomes 2. Kern-Goldberger AR, Srinivas SK. Obstetrical pregnancy in a regional maternity hospital: po-
for the two RPM groups for the overall telehealth and virtual care practices during the tential scope for increased self-management
comparison of RPM versus traditional COVID-19 pandemic. Clin Obstet Gynecol and remote patient monitoring through
management with paper glucose logs. 2022;65:148–60. mhealth solutions. BMC Health Serv Res
3. Morgan A, Goodman D, Vinagolu-Baur J, 2019;19:662.
Our sample size was both a strength 16. Centers for Disease Control and Prevention,
Cass I. Prenatal telemedicine during COVID-19:
and limitation. Although our study patterns of use and barriers to access. JAMIA Division of Reproductive Health. Diabetes during
examining RPM for the management of Open 2022;5:ooab116. pregnancy. 2018. Available at: https://www.
diabetes mellitus in pregnancy is among 4. Society for Maternal-Fetal Medicine (SMFM). cdc.gov/reproductivehealth/maternalinfanthealth/
the largest on this subject, there may be Electronic address: [email protected], Healy A, diabetes-during-pregnancy.htm. Accessed
Davidson C, et al. Society for Maternal-Fetal November 27, 2022.
certain clinical benefits of RPM that we 17. ACOG Practice Bulletin No. 190: gestational
Medicine Special Statement: Telemedicine in
were still unable to detect because of obstetrics-quality and safety considerations. Am diabetes mellitus. Obstet Gynecol 2018;131:
sample size. For example, there was a J Obstet Gynecol 2023;228:B8e17. e49–64.
trend toward a decreased rate of LGA 5. Zork NM. Telehealth for the management of 18. Shah NS, Wang MC, Freaney PM, et al.
neonates in the group managed by RPM, diabetes in pregnancy. Curr Diab Rep 2022;22: Trends in gestational diabetes at first live birth by
365–9. race and ethnicity in the US, 2011-2019. JAMA
but this did not reach statistical signifi- 2021;326:660–9.
6. Farmer AJ, Gibson OJ, Dudley C, et al.
cance. Similarly, the neonatal composite A randomized controlled trial of the effect of real- 19. Davitt C, Flynn KE, Harrison RK, Pan A,
morbidity was somewhat higher in the time telemedicine support on glycemic control in Palatnik A. Current practices in gestational
paper glucose log group, but this was not young adults with type 1 diabetes (ISRCTN diabetes mellitus diagnosis and management in
statistically significant. It is possible that 46889446). Diabetes Care 2005;28:2697–702. the United States: survey of maternal-fetal
7. Marcolino MS, Maia JX, Alkmim MBM, medicine specialists. Am J Obstet Gynecol
with a larger study population, we would 2021;225:203–4.
Boersma E, Ribeiro AL. Telemedicine applica-
find that there are significant differences tion in the care of diabetes patients: systematic 20. Bardenheier BH, Imperatore G, Gilboa SM,
between the groups for these outcomes. review and meta-analysis. PLoS One 2013;8: et al. Trends in gestational diabetes among
Another limitation is the fact that this e79246. hospital deliveries in 19 U.S. states, 2000-
study was performed at a single institu- 8. Mackillop L, Loerup L, Bartlett K, et al. 2010. Am J Prev Med 2015;49:12–9.
Development of a real-time smartphone solution 21. Yuen L, Wong VW. Gestational diabetes
tion. Rolling out this RPM model at
for the management of women with or at high mellitus: challenges for different ethnic groups.
multiple hospitals and repeating this risk of gestational diabetes. J Diabetes Sci World J Diabetes 2015;6:1024–32.
study with multiple sites would Technol 2014;8:1105–14. 22. Getahun D, Nath C, Ananth CV, Chavez MR,
strengthen the generalizability of our 9. Miremberg H, Ben-Ari T, Betzer T, et al. The Smulian JC. Gestational diabetes in the
results. impact of a daily smartphone-based feedback United States: temporal trends 1989 through
system among women with gestational diabetes 2004. Am J Obstet Gynecol 2008;198:525.
on compliance, glycemic control, satisfaction, e1–15.
Conclusion and pregnancy outcome: a randomized 23. Hunt KJ, Schuller KL. The increasing prev-
RPM for outpatient management of controlled trial. Am J Obstet Gynecol 2018;218: alence of diabetes in pregnancy. Obstet Gynecol
diabetes mellitus in pregnancy is 453.e1–7. Clin North Am 2007;34:173–99, vii.
24. Pu J, Zhao B, Wang EJ, et al. Racial/ethnic treating. Am J Obstet Gynecol 2005;192: gestational diabetes mellitus - the importance of
differences in gestational diabetes prevalence 989–97. neonatal ponderal index. J Matern Fetal
and contribution of common risk factors. Pae- 36. Langer O, Levy J, Brustman L, Neonatal Med 2012;25:267–71.
diatr Périnat Epidemiol 2015;29:436–43. Anyaegbunam A, Merkatz R, Divon M. Glycemic 46. The Fetal Medicine Foundation. Birth
25. Yogev Y, Xenakis EMJ, Langer O. The as- control in gestational diabetes mellitus–how tight weight assessment. 2022. Available at: https://
sociation between preeclampsia and the is tight enough: small for gestational age versus fetalmedicine.org/research/assess/bw. Accessed
severity of gestational diabetes: the impact of large for gestational age? Am J Obstet Gynecol November 25, 2022.
glycemic control. Am J Obstet Gynecol 1989;161:646–53. 47. Nicolaides KH, Wright D, Syngelaki A,
2004;191:1655–60. 37. Suhonen L, Hiilesmaa V, Teramo K. Gly- Wright A, Akolekar R. Fetal Medicine Foundation
26. Ehrenberg HM, Durnwald CP, Catalano P, caemic control during early pregnancy and fetal fetal and neonatal population weight charts. Ul-
Mercer BM. The influence of obesity and dia- malformations in women with type I diabetes trasound Obstet Gynecol 2018;52:44–51.
betes on the risk of cesarean delivery. Am J mellitus. Diabetologia 2000;43:79–82. 48. Ramani S, Halpern TA, Akerman M,
Obstet Gynecol 2004;191:969–74. 38. Holmes VA, Young IS, Patterson CC, et al. Ananth CV, Vintzileos AM. A new index for ob-
27. Zeki R, Li Z, Wang AY, et al. Obstetric anal Optimal glycemic control, pre-eclampsia, and stetrics safety and quality of care: integrating
sphincter injuries among women with gesta- gestational hypertension in women with type 1 cesarean delivery rates with maternal and
tional diabetes and women without gestational diabetes in the diabetes and pre-eclampsia neonatal outcomes. Am J Obstet Gynecol
diabetes: a NSW population-based cohort intervention trial. Diabetes Care 2011;34: 2022;226:556.e1–9.
study. Aust N Z J Obstet Gynaecol 2019;59: 1683–8. 49. Oshima SM, Tait SD, Thomas SM, et al.
662–9. 39. Landon MB, Spong CY, Thom E, et al. Association of smartphone ownership and
28. Øverland EA, Vatten LJ, Eskild A. Pregnancy A multicenter, randomized trial of treatment for internet use with markers of health literacy and
week at delivery and the risk of shoulder mild gestational diabetes. N Engl J Med access: cross-sectional survey study of per-
dystocia: a population study of 2,014,956 de- 2009;361:1339–48. spectives from project PLACE (Population Level
liveries. BJOG 2014;121:34–41. 40. Hartling L, Dryden DM, Guthrie A, Muise M, Approaches to Cancer Elimination). J Med
29. Kc K, Shakya S, Zhang H. Gestational dia- Vandermeer B, Donovan L. Benefits and harms Internet Res 2021;23:e24947.
betes mellitus and macrosomia: a literature re- of treating gestational diabetes mellitus: a sys- 50. Leziak K, Birch E, Jackson J, Strohbach A,
view. Ann Nutr Metab 2015;66(Suppl2):14–20. tematic review and meta-analysis for the U.S. Niznik C, Yee LM. Identifying mobile health
30. Rosenstein MG, Cheng YW, Snowden JM, Preventive Services Task Force and the Na- technology experiences and preferences of low-
Nicholson JM, Doss AE, Caughey AB. The risk of tional Institutes of Health office of medical ap- income pregnant women with diabetes.
stillbirth and infant death stratified by gestational plications of research. Ann Intern Med J Diabetes Sci Technol 2021;15:1018–26.
age in women with gestational diabetes. Am J 2013;159:123–9.
Obstet Gynecol 2012;206:309.e1–7. 41. Murphy HR, Bell R, Cartwright C, et al.
31. Mitanchez D, Yzydorczyk C, Simeoni U. Improved pregnancy outcomes in women with Author and article information
What neonatal complications should the pedia- type 1 and type 2 diabetes but substantial clinic- From the Division of Maternal-Fetal Medicine, Depart-
trician be aware of in case of maternal gesta- to-clinic variations: a prospective nationwide ment of Obstetrics and Gynecology, NYU Langone Hos-
tional diabetes? World J Diabetes 2015;6: study. Diabetologia 2017;60:1668–77. pital e Long Island, Mineola, NY (Dr Kantorowska, Ms
734–43. 42. Guo L, Ma J, Tang J, Hu D, Zhang W, Wise, and Drs Chavez and Heo); NYU Long Island School
32. Watson D, Rowan J, Neale L, Battin MR. Zhao X. Comparative efficacy and safety of of Medicine, Mineola, NY (Dr Kantorowska, Ms Cohen, Mr
Admissions to neonatal intensive care unit metformin, glyburide, and insulin in treating Oberlander, Ms Jaysing, and Drs Chavez and Heo);
following pregnancies complicated by gesta- gestational diabetes mellitus: a meta-analysis. Department of Biostatistics, NYU Langone Hospital e
tional or type 2 diabetes. Aust N Z J Obstet J Diabetes Res 2019;2019:9804708. Long Island, Mineola, NY (Ms Akerman); MCIT Clinical
Gynaecol 2003;43:429–32. 43. Yee LM, McGuire JM, Taylor SM, Niznik CM, Informatics, NYU Grossman School of Medicine, NYU
33. Inkster ME, Fahey TP, Donnan PT, Simon MA. Factors promoting diabetes self- Langone Medical Center, New York, NY (Drs Mann, Testa,
Leese GP, Mires GJ, Murphy DJ. Poor glycated care among low-income, minority pregnant and Heo); and Department of Obstetrics and Gynecology,
haemoglobin control and adverse pregnancy women. J Perinatol 2016;36:13–8. Lenox Hill Hospital, Northwell Health, New York, NY (Dr
outcomes in type 1 and type 2 diabetes mellitus: 44. Nielsen KK, Kapur A, Damm P, de Vintzileos).
systematic review of observational studies. BMC Courten M, Bygbjerg IC. From screening to Received Dec. 9, 2022; revised Feb. 19, 2023;
Pregnancy Childbirth 2006;6:30. postpartum follow-up - the determinants and accepted Feb. 20, 2023.
34. Buhary BM, Almohareb O, Aljohani N, et al. barriers for gestational diabetes mellitus (GDM) The authors report no conflict of interest.
Glycemic control and pregnancy outcomes in services, a systematic review. BMC Pregnancy This study did not receive any financial support.
patients with diabetes in pregnancy: a retro- Childbirth 2014;14:41. This study was presented at the 43rd annual meeting
spective study. Indian J Endocrinol Metab 45. Ramos GA, Hanley AA, Aguayo J, of the Society for Maternal-Fetal Medicine, San Fran-
2016;20:481–90. Warshak CR, Kim JH, Moore TR. Neonatal cisco, CA, February 6e11, 2023.
35. Langer O, Yogev Y, Most O, Xenakis EMJ. chemical hypoglycemia in newborns from Corresponding author: Agata Kantorowska, MD.
Gestational diabetes: the consequences of not pregnancies complicated by type 2 and [email protected]